1. Home
  2. EVOK vs OBLG Comparison

EVOK vs OBLG Comparison

Compare EVOK & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • OBLG
  • Stock Information
  • Founded
  • EVOK 2007
  • OBLG 2000
  • Country
  • EVOK United States
  • OBLG United States
  • Employees
  • EVOK N/A
  • OBLG N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • EVOK Health Care
  • OBLG Technology
  • Exchange
  • EVOK Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • EVOK 4.2M
  • OBLG 4.5M
  • IPO Year
  • EVOK 2013
  • OBLG N/A
  • Fundamental
  • Price
  • EVOK $2.95
  • OBLG $3.10
  • Analyst Decision
  • EVOK
  • OBLG
  • Analyst Count
  • EVOK 0
  • OBLG 0
  • Target Price
  • EVOK N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • EVOK 14.3K
  • OBLG 176.6K
  • Earning Date
  • EVOK 05-13-2025
  • OBLG 05-13-2025
  • Dividend Yield
  • EVOK N/A
  • OBLG N/A
  • EPS Growth
  • EVOK N/A
  • OBLG N/A
  • EPS
  • EVOK N/A
  • OBLG N/A
  • Revenue
  • EVOK $11,594,083.00
  • OBLG $2,374,000.00
  • Revenue This Year
  • EVOK $57.82
  • OBLG N/A
  • Revenue Next Year
  • EVOK $59.12
  • OBLG N/A
  • P/E Ratio
  • EVOK N/A
  • OBLG N/A
  • Revenue Growth
  • EVOK 89.89
  • OBLG N/A
  • 52 Week Low
  • EVOK $1.94
  • OBLG $1.91
  • 52 Week High
  • EVOK $12.32
  • OBLG $13.60
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 38.86
  • OBLG 44.18
  • Support Level
  • EVOK $3.33
  • OBLG $3.33
  • Resistance Level
  • EVOK $3.66
  • OBLG $3.96
  • Average True Range (ATR)
  • EVOK 0.29
  • OBLG 0.40
  • MACD
  • EVOK -0.06
  • OBLG -0.02
  • Stochastic Oscillator
  • EVOK 2.99
  • OBLG 17.93

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: